Early Prognostic Biomarkers of Non-Relapse Mortality in Allogeneic Mismatched Unrelated Hematopoietic Cell Transplantation

被引：0
|
作者：
Wang, Trent [1 ]
Crawford, Anna [2 ]
Fu, Denggang [3 ]
Hill, Elizabeth [3 ]
Jimenez, Antonio M. Jimenez [4 ]
Komanduri, Krishna V. [5 ]
Paczesny, Sophie [3 ]
机构：
[1] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Div Hematol, Miami, FL USA
[2] Med Univ South Carolina, Hollings Canc Ctr, Charleston, SC USA
[3] Med Univ South Carolina, Charleston, SC USA
[4] Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL USA
[5] UCSF, San Francisco, CA USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-180944
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Major ABO mismatch is associated with increased non-relapse mortality in alemtuzumab-conditioned unrelated donor allogeneic haematopoietic stem cell transplantation
    Brierley, C. K.
    Littlewood, T. J.
    Staves, J.
    Danby, R.
    Rowley, L. E.
    Ansari, N.
    Gooding, S.
    Peniket, A. J.
    Medd, P. G.
    BRITISH JOURNAL OF HAEMATOLOGY, 2011, 153 : 18 - 18
  • [42] Major ABO mismatch is associated with increased non-relapse mortality in Alemtuzumab-conditioned unrelated donor allogeneic haematopoietic stem cell transplantation
    Brierley, C. K.
    Littlewood, T. J.
    Staves, J.
    Danby, R.
    Rowley, L.
    Ansari, N.
    Gooding, S.
    Peniket, A. J.
    Medd, P. G.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S51 - S52
  • [43] Comorbidities Exert Regimen-Specific Effects on Non-Relapse Mortality in Allogeneic Stem Cell Transplantation
    Fein, Joshua
    Labopin, Myriam
    Shem-Tov, Noga
    Yerushalmi, Ronit
    Danylesko, Ivetta
    Nadav, Furie
    Shimoni, Avichai
    Nagler, Arnon
    Shouval, Roni
    BONE MARROW TRANSPLANTATION, 2018, 53 : 16 - 17
  • [44] ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THE ELDERLY PREDICTING THE RISK FOR NON RELAPSE MORTALITY
    Berro, Mariano
    Basquiera, Ana L.
    Rivas, Maria M.
    Cecilia Foncuberta, Maria
    Burgos, Ruben
    Jaimovich, Gregorio
    Milovic, Vera
    Martinez Rolon, Juliana
    Remaggi, Guillermina
    Alberbide, Jorge
    Milone, Jorge
    Prates, Virginia
    Rizzi, Maria L.
    Jarchum, Gustavo
    Jose Garcia, Juan
    Kusminsky, Gustavo
    MEDICINA-BUENOS AIRES, 2015, 75 (04) : 201 - 206
  • [45] Routine Computed Tomography before Pediatric Hematopoietic Stem Cell Transplantation and Association with Length of Stay and Early Non-Relapse Mortality
    Taylor, David
    Lim, Shawn
    Moore, Caitlin
    King, Shereene
    Haines, Hilary
    Phadnis, Sheetal
    Goldman, Frederick
    Chewning, Joseph
    Wadhwa, Aman
    BLOOD, 2023, 142
  • [46] Allogeneic stem cell transplantation in acute myeloid leukemia in first or subsequent remission: Weighing prognostic markers predicting relapse and risk factors for non-relapse mortality
    Meijer, Ellen
    Cornelissen, Jan J.
    SEMINARS IN ONCOLOGY, 2008, 35 (04) : 449 - 457
  • [47] Mismatched Related and Unrelated Donors for Allogeneic Hematopoietic Cell Transplantation for Adults with Hematologic Malignancies
    Eapen, Mary
    O'Donnell, Paul
    Brunstein, Claudio G.
    Wu, Juan
    Barowski, Kate
    Mendizabal, Adam
    Fuchs, Ephraim J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (10) : 1485 - 1492
  • [48] IMPROVED NON-RELAPSE MORTALITY AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION OVER 3 DECADES: A SINGLE-INSTITUTION HISTORICAL EXPERIENCE
    Malard, F.
    Chevallier, P.
    Guillaume, T.
    Delaunay, J.
    Legouill, S.
    Harrousseau, J. -L.
    Moreau, P.
    Milpied, N.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S86 - S86
  • [49] Comorbidity from Solid Tumor or Hematologic Malignancy Prior to Allogeneic Hematopoietic Cell Transplantation (HCT) May Both Increase Non-Relapse Mortality
    D'Angelo, Christopher Robert
    Novitsky, Brianna
    Lee, Sang Mee
    Godley, Lucy A.
    Kline, Justin
    Larson, Richard A.
    Liu, Hongtao
    Odenike, Olatoyosi
    Stock, Wendy
    Bishop, Michael R.
    Artz, Andrew
    BLOOD, 2016, 128 (22)
  • [50] Social Economic Status Is Associated with a Lower Non-Relapse Mortality Rate and an Increased Overall Survival after Allogeneic Hematopoietic Stem Cell Transplantation
    Galvin, John P.
    Ehrlich, Katherine
    Baveja, Swati
    Scheide, Thomas
    Valukas, Catherine
    Penedo, Frank
    Miller, Greg
    Mehta, Jayesh
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S175 - S176
12345